Robeco Institutional Asset Management B.V. Lowers Position in Intuitive Surgical, Inc. $ISRG

Robeco Institutional Asset Management B.V. cut its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 145,904 shares of the medical equipment provider’s stock after selling 2,072 shares during the period. Robeco Institutional Asset Management B.V.’s holdings in Intuitive Surgical were worth $65,253,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Norway Savings Bank lifted its holdings in shares of Intuitive Surgical by 53.4% during the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after acquiring an additional 910 shares during the last quarter. Trust Co. of Oklahoma purchased a new stake in Intuitive Surgical during the second quarter valued at about $363,000. IronOak Wealth LLC. bought a new stake in Intuitive Surgical during the second quarter worth about $1,099,000. Amalgamated Bank boosted its holdings in shares of Intuitive Surgical by 2.2% in the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after purchasing an additional 1,772 shares in the last quarter. Finally, Eastover Investment Advisors LLC increased its position in shares of Intuitive Surgical by 204.8% during the 2nd quarter. Eastover Investment Advisors LLC now owns 13,163 shares of the medical equipment provider’s stock valued at $7,153,000 after purchasing an additional 8,844 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Trading Up 4.7%

ISRG stock opened at $592.85 on Wednesday. The stock has a market capitalization of $212.52 billion, a price-to-earnings ratio of 78.42, a PEG ratio of 4.61 and a beta of 1.67. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The firm’s 50-day moving average price is $562.72 and its two-hundred day moving average price is $509.94.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share for the quarter, topping the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The business’s revenue was up 22.9% on a year-over-year basis. During the same quarter last year, the business posted $1.84 EPS. Equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Wall Street Analyst Weigh In

ISRG has been the subject of a number of recent research reports. Argus boosted their target price on Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Mizuho set a $575.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Leerink Partners upped their price objective on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. HSBC lifted their target price on shares of Intuitive Surgical from $595.00 to $644.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Finally, Raymond James Financial set a $603.00 price target on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $612.75.

Insider Buying and Selling

In related news, EVP Henry L. Charlton sold 13,731 shares of Intuitive Surgical stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the sale, the executive vice president owned 3,056 shares in the company, valued at $1,772,480. The trade was a 81.80% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Gary S. Guthart sold 22,806 shares of the business’s stock in a transaction on Monday, December 1st. The shares were sold at an average price of $570.89, for a total transaction of $13,019,717.34. Following the transaction, the insider directly owned 2,694 shares in the company, valued at approximately $1,537,977.66. The trade was a 89.44% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 114,007 shares of company stock valued at $63,533,844 over the last three months. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.